As Denmark begins talkswith the United States over a potential Greenland deal, the country’s largest industry may not give it much leverage in negotiations, experts told Euronews Health. Denmark’s top ...

March 4 () - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance use disorders ...

Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by ...

Novo Nordisk, Denmark’s fat jab pharmaceutical giant, reached an unwelcome milestone last week. After a dizzying 76pc plunge ...

Almost £150bn has been wiped off Ozempic drugmaker Novo Nordisk after a trial of its new weight-loss drug fell short of ...

The popular weight loss drugs are both listed at more than $1,000 per month. The price cut is set for Jan. 1, 2027.

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result ...

Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.

Americans spent an average of $1,514 out of pocket on medical care in 2023, which is 25.3% of Ozempic's annual self-pay cost of $5,988. Ozempic slims more than your waist — if you’re paying out of ...